 nimodipin resuscit out-of-hospit ventricular fibril placebo-control double-blind random trial fifty-f consecut patient out-of-hospit ventricular fibril physician-man advanc life support unit nimodipin placebo dosag micrograms/kg intraven inject restor spontan circul infus micrograms/kg minut hour signific differ surviv rate nimodipine-tr patient placebo-tr patient patient recurr ventricular fibril treatment patient nimodipin group patient placebo group post hoc analysi patient long delay advanc life support minut surviv rate nimodipin patient placebo patient nimodipin benefit patient delay resuscit